Difference between revisions of "DZI20-210-Case-22"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 43: Line 43:
 
|subject=Z0FBQUFBQmZrRkdsLVRzeUFwZF9yU2hJLTV1Y0hqZDZ3VHJNT1VYSXowYlJ6LW84R3J0d3IzVTNQbWh5Z1lXdG5VcTdOUTB1YU8yS3NaaFVlenBESmtVMUljZkRTREctZVE9PQ
 
|subject=Z0FBQUFBQmZrRkdsLVRzeUFwZF9yU2hJLTV1Y0hqZDZ3VHJNT1VYSXowYlJ6LW84R3J0d3IzVTNQbWh5Z1lXdG5VcTdOUTB1YU8yS3NaaFVlenBESmtVMUljZkRTREctZVE9PQ
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Vn048
 +
|authoredOn=October 21, 2020 03:17:32 PM
 
}}
 
}}

Latest revision as of 14:01, December 9, 2024

DZI20-210-Case-22
Multiple cutaneous lesions (chest, buttock, scalp, back).
Skin, (parietal scalp? left buttock? right lateral chest? Lower mid spinal back?): CD8+ epidermotropic T-cell lymphoma.

IHC: The vast majority of lymphocytes are CD3+ BF1+, TIA1, CD8+ Granzyme B+, CD2+ CD7+ CD4- CD5-.CD56- CD30-. Mib1 is ~60%.

Note: Buttock lesion with few epidermotropic cells with hyperchromatic nuclei could be incipient lesion or drug/viral exanthem.
December 31, 1969 7:00:00 PM